• Alexandre O Ferreira, Joana Torres, Mário Dinis-Ribeiro, and Marília Cravo.
• aDepartment of Gastroenterology, Centro Hospitalar do Algarve - Portimão Unit, Portimão bGastroenterology Unit, Department of Surgery, Hospital Beatriz Ângelo, Loures cGastroenterology Department, Oncology Portuguese Institute of Porto, Porto, Portugal.
• Eur J Gastroenterol Hepatol. 2015 Mar 1; 27 (3): 265-70.

BackgroundNational surveys have been used to obtain information on sedation and monitoring practices in endoscopy in several countries.AimsTo provide data from Portugal and query the Portuguese endoscopists on nonanesthesiologist administration of propofol.Materials And MethodsA 31-item web survey was sent to all 490 members of the Portuguese Society of Gastroenterology.ResultsA total of 129 members (26%) completed the questionnaire; 57% worked in both public and private practice. Most performed esophagogastroduodenoscopy without sedation (public - 70%; private - 57%) and colonoscopies with sedation (public - 64%; private - 69%). Propofol was the most commonly used agent for colonoscopy, especially in private practice (52 vs. 33%), and it provided the best satisfaction (mean 9.6/10). A total of 94% chose propofol as the preferred sedation for routine colonoscopy. Nonanesthesiologist administration of propofol was performed only by four respondents; however, 71% reported that they would consider its use, given adequate training. Pulse oximetry is monitored routinely (99%); oxygen supplementation is administered by 81% with propofol and 42% with traditional sedation. Most (82%) believed that propofol sedation may increase the uptake of endoscopic screening for colorectal cancer.ConclusionThe use of sedation is routine practice in colonoscopy, but not esophagogastroduodenoscopy. The preferred agent is propofol and it is used almost exclusively by anesthesiologists.

24 keywords...

hide…